Indian peripheral neuropathy treatment market is estimated to grow at a CAGR of 5.8% during the forecast period. The rising prevalence of diabetes is a major factor in accelerating market growth. As per the International Diabetes Federation (IDF), In India, the total cases of diabetes in adults were nearly 77 million in 2019. The most common diabetic complication is peripheral neuropathy. It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This condition affects the legs and feet first and is followed by hands and arms. This results in an increasing demand for diabetic peripheral neuropathy treatment in the country. Some antidepressants provide ease to nerve pain. Tricyclic antidepressants may support mild to moderate nerve pain. This class of drugs includes imipramine (Tofranil), amitriptyline, and desipramine (Norpramin). 

Visit for Global Peripheral Neuropathy Treatment Market Report at: https://www.omrglobal.com/industry-reports/peripheral-neuropathy-treatment-market

Indian peripheral neuropathy treatment market is segmented based on type and application. Based on type, the market is classified into antidepressants, pain relievers, antiseizure, and others. Based on the application, the market is classified into diabetes, chemotherapy-induced, and others. Rising cancer prevalence is leading to increasing demand for chemotherapy in the country. As per the World Health Organization (WHO), the number of new cancer incidences in India was nearly 1.1 million in 2018. This, in turn, is resulting in the demand for chemotherapy-induced peripheral neuropathy treatment in the country. 

Some prominent players in the market include Alembic Pharmaceuticals Ltd., Cipla Ltd., Eli Lilly and Co., and Pfizer Inc. Product launches and partnerships and collaborations are regarded as some potential strategies implemented by the market players to increase their position in the marketplace. For instance, in July 2019, Cipla declared that InvaGen Pharmaceuticals, its subsidiary gained US approval for Pregabalin Capsules, which is intended for neuropathic pain management associated with some illnesses. InvaGen gained approval from the US FDA for the drug in the strengths of 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg.

Research Methodology

The market study of the Indian peripheral neuropathy treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Indian Peripheral Neuropathy Treatment Market Research and Analysis by Type
2. Indian Peripheral Neuropathy Treatment Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the Indian peripheral neuropathy treatment market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian peripheral neuropathy treatment market.
• Insights about market determinants which are stimulating the Indian peripheral neuropathy treatment market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.